Auriga Reiterates a 'Buy' on MedAssets (MDAS); See 30% Upside in Next 12-Months
Tweet
Share
E-mailGet Alerts MDAS Hot Sheet
Price: $31.35 --0%
Rating Summary:
3 Buy, 20 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 14
Rating Summary:
3 Buy, 20 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 14
Join SI Premium – FREE
Auriga reiterates a 'Buy' on MedAssets (NASDAQ: MDAS) price target of $16.00.
Analyst, Gene Mannheimer, said, "MDAS following a strong quarter in which the company over-attained on revenue and earnings. However, the outperformance was due to early recognition of performance based fees, so there is no change to full-year guidance as this comes out of future quarters. We think MDAS is taking the proper steps to right the ship as it upgrades its operational teams, focuses on improving client satisfaction and steadily digs out of its heavy debt burden. We're not looking for results overnight, but think there is 30% upside in the name over a 12-month term."
For an analyst ratings summary and ratings history on MedAssets click here. For more ratings news on MedAssets click here.
Shares of MedAssets closed at $12.24 yesterday.
Analyst, Gene Mannheimer, said, "MDAS following a strong quarter in which the company over-attained on revenue and earnings. However, the outperformance was due to early recognition of performance based fees, so there is no change to full-year guidance as this comes out of future quarters. We think MDAS is taking the proper steps to right the ship as it upgrades its operational teams, focuses on improving client satisfaction and steadily digs out of its heavy debt burden. We're not looking for results overnight, but think there is 30% upside in the name over a 12-month term."
For an analyst ratings summary and ratings history on MedAssets click here. For more ratings news on MedAssets click here.
Shares of MedAssets closed at $12.24 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EQT Corp. (EQT) PT Lowered to $46 at Wolfe Research
- JPMorgan on Tesla (TSLA): 'See Risk of Further Negative Earnings Revisions'
- Root, Inc. (ROOT) PT Raised to $70 at Keefe, Bruyette & Woods
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS ViewRelated Entities
Auriga, EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
